Team

Based in San Francisco, California.

Elena Arzumanyan CEO, Co-Founder

1x exit. Molecular biology PhD at Moscow State. Founded $1M+ revenue without VC funding. Co-developed early cancer detection assay for 9 cancers at Avida Biomed (acquired by Agilent). Led rare disease assay at Natera.

Jesse Eaton CTO, Co-Founder

Trained LLMs at Meta. Computational biology MS at Carnegie Mellon. Built the machine learning model for the largest colorectal cancer blood test (49k participants) at Freenome.

Jay Sarkar CSO, Co-Founder

Serial entrepreneur. Biophysics PhD from Stanford. Co-founder of Turn Biotechnologies, a Stanford-born startup pioneering epigenetic reprogramming to reverse cellular aging. Physics & EE BS from Rice.

Polina Prikhodko Research Intern

Biology and computer science background. Independent research in skin cancer classification using deep learning. Supports genomic analysis workflows and partner research.

Advisors

Mike Cassidy Advisor

5x exits totaling $750M+ including Direct Hit, Xfire, and Apollo Fusion. Former Google VP and Project Loon lead. MIT & Harvard Business School. Has advised 300+ startups.

Nadav Ahituv Scientific Advisor

Professor at UCSF and Director of the Institute for Human Genetics. Co-developer of massively parallel reporter assays (MPRA) and a leader in gene regulation. PhD in human genetics from Tel Aviv University.